As featured in Vermont Public,
@marycushmanmd.bsky.social and Nels Olson, Ph.D., M.P.H. are #UVMLarnerMed researchers who co-authored a new publication in Neurology Journals related to blood tests that could help predict a person's risk for dementia. #dementia #alzheimers @uvmvermont.bsky.social

UVM develops new vaccine to prevent dengue, a highly contagious disease The disease is mainly found in warm areas like Brazil, Kenya and Florida, and researchers said the vaccine will greatly reduce the risk of infection.

Big news for those who live in countries with dengue fever thanks to 16 years of studies and clinical trials conducted at the #UVMLarnerMed Vaccine Testing Center at UVM, @johnshopkinssph.bsky.social and the U.S. NIH. www.mynbc5.com/article/univ... #dengue #denguevaccine @uvmvermont.bsky.social

Big news for those who live in countries with dengue fever thanks to 16 years of studies and clinical trials conducted at the #UVMLarnerMed Vaccine Testing Center, @johnshopkinssph.bsky.social and U.S. NIH.

Big news for those who live in countries with dengue fever thanks to 16 years of studies and clinical trials conducted at the #UVMLarnerMed Vaccine Testing Center, @JohnsHopkinsSPH
and @NIH! #dengue #denguefever

Rural Health | The University of Vermont Sixty-five percent of Vermont’s population lives in rural areas—the highest percentage in the nation. Local health care providers are essential in delivering care across the state.

In celebration of National Rural Health Day, explore how #UVMLarnerMed serves the health care needs of rural Vermont communities: uvm.edu/larnermed/ru... #ruralhealth #powerofrural @uvmvermont.bsky.social

#UVMLarnerMed research publication alert! #Brainresearch by authors Osama Harraz, Ph.D., and Ahmed Hashad, Ph.D., Department of Pharmacology, Larner College of Medicine, Vermont Center for Cardiovascular and Brain Health.
@uvmvermont.bsky.social @apspublications.bsky.social

The endocrine complications of cystic fibrosis - Nature Reviews Endocrinology Cystic fibrosis is associated with multiple endocrine complications, which are caused by systemic dysfunction of the cystic fibrosis transmembrane conductance regulator protein. In this Review, Moheet...

New publication in Nature Reviews #Endocrinology on #cysticfibrosis! Congratulations faculty member Samantha Steinmetz-Wood, M.D., assistant professor at #UVMLarnerMed and endocrinologist at @uvmhealth.bsky.social :
www.nature.com/articles/s41... @uvmvermont.bsky.social @springernature.com

Last week, #UVMLarnerMed professor of medicine, Christopher Huston, M.D. @uvmhealth.bsky.social infectious disease physician, Chris Huston, M.D., discussed #cryptosporidium treatments with @johnshopkinsmmi.bsky.social. @uvmvermont.bsky.social

This month, Kara Landry, M.D., Assistant Professor of Medicine at #UVMLarnerMed and Medical Oncologist at #UVMHealth, spoke with Across the Fence about breast cancer risk, detection, prevention, genetic testing, and treatment. View:
youtu.be/Q8QdMoGQCtk #BreastCancerAwareness @uvmvermont.bsky.social

National Academy of Medicine Announces Election of Larner’s Dr. Peter Calabresi as New Member | Office of Medical Communications | The University of Vermont

National Academy of Medicine announces election of Peter A. Calabresi, M.D.—professor and chair, Dept. of Neurological Sciences at #UVMLarnerMed —as a new member, due to his leadership in #MS pathogenesis/therapies: go.uvm.edu/uvmnam @nationalacademies.org @uvmvermont.bsky.social

Congratulations to our Dean’s Celebration in Research Excellence award winners for 2025, including Jeremy Barry, Ph.D., Mid-Career Investigator, Associate Professor of Neurological Sciences at #UVMLarnerMed @jeremybarry.bsky.social @uvmvermont.bsky.social #research #larnerresearch #uvmresearch

Last Friday's #UVMLarnerMed Class of 2029 White Coat Ceremony—full of joy, proud smiles, and unforgettable energy! View all photos from the day: go.uvm.edu/wc2025 (Photos: David Seaver)
@uvmvermont.bsky.social #whitecoat #UVMFutureDocs

Introducing the“My Why” campaign... We invite all #UVMLarnerMed researchers to share the motivations driving their work so we can shine a light on the essential role of research and funding in advancing medicine. Share your 'why' at: go.uvm.edu/mywhy
#MyWhy #research @uvmvermont.bsky.social

Last week at the Dean’s Celebration of Excellence in Research, the annual #UVMLarnerMed Research Rally showcased inspiring research by faculty scientists. Learn more about #larnerresearch at go.uvm.edu/lcomresearch #medicalresearch #research
@uvmvermont.bsky.social
@osamaharraz.bsky.social

Celebrating yesterday's big announcement ... #UVMLarnerMed Class of 2017 Alum Imelda Muller, M.D. named #NASA astronaut candidate! Details: go.uvm.edu/astronaut 👩‍🚀🚀🛰️🪐🩺 #space #astronaut #larneralum @hopkinsmedicine.bsky.social

Excellence in Research | The University of Vermont The Dean's Celebration of Excellence in Research is an annual event highlighting the research being conducted by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the Uni...

Join us for the #UVMLarnerMed Dean’s Celebration of Excellence in Research from September 22 – 26, 2025.
View more details about the week’s schedule at go.uvm.edu/research25 @uvmvermont.bsky.social

Global Barriers to the Diagnosis of Multiple Sclerosis | Neurology Background and ObjectivesRecent data suggest increasing global prevalence of multiple sclerosis (MS). Early diagnosis of MS reduces the burden of disability-adjusted life years and associated health c...

📢New #MultipleSclerosis study led by #UVMLarnerMed interim chair and professor of neurological sciences, Andrew Solomon, M.D., entitled "Global Barriers to the Diagnosis of Multiple Sclerosis" published in the journal @Neurology: www.neurology.org/doi/10.1212/... @uvmvermont.bsky.social #neurology

Public Health On Call Podcast | Johns Hopkins Bloomberg School of Public Health Evidence and experts to help you understand today’s public health news—and what it means for tomorrow.

Joshua M. Sharfstein, M.D. welcomed #pediatricians Heidi Schumacher, M.D., Assoc. Professor at #UVMLarnerMed and Dr. Deanne Haag to the Public Health On Call podcast about work on school attendance, a public health priority. @uvmvermont.bsky.social
@johnshopkinssph.bsky.social
🎧:go.uvm.edu/schools

#UVMLarnerMed Alums... Registration is open for the 2025 Larner College of Medicine Reunion Oct 10-12! Campus will be alive with activities & alums in classes ending in ’0 and ’5 are especially encouraged to join us. Register: go.uvm.edu/medreunion
@uvmvermont.bsky.social
#lcomreunion

Resolving zone-specific regulation of cardiac myosin | Journal of General Physiology | Rockefeller University Press Pilagov and colleagues explore role of MyBP-C in regulation of the myosin SRX state in cardiac muscle.

Commentary published by Shane Nelson, Ph.D., faculty scientist in the Warshaw Lab at #UVMLarnerMed, Department of Molecular Physiology and Biophysics doi.org/10.1085/jgp.... @uvmvermont.bsky.social #physiology #myosin

Rurality Does Not Impact Outcomes of Glioblastoma Patients Diagnosed at UVMMC | UVM Cancer Center | The University of Vermont Login to your UVM Dashboard

Faculty Publication alert📣! Congratulations Alissa Thomas, M.D., #UVMLarnerMed assistant professor, department of neurology, and neuro-oncologist at UVM Medical Center on new study in @BioMedCentral: go.uvm.edu/rurality
@uvmvermont.bsky.social #ruralmedicine #ruralhealth

Celebrating cooperation for acceleration of breakthroughs in #cancercare. #UVMLarnerMed 's Brian Cunniff, Ph.D., asst. professor, pathology & laboratory medicine, UVM Cancer Center member, was appointed as Honorary Visiting Fellow at U of Leicester, UK, to continue research. @uvmvermont.bsky.social

The UVM Cancer Center Summer Research Fellowship poster session kicked off this morning, with @uvmvermont.bsky.social undergrads, graduate, and #UVMLarnerMed students showcasing research conducted with UVMCC members. #cancerresearch

A cannabinoid receptor 1 inverse agonist induces weight loss and reduces airway hyperresponsiveness in a mouse model of obese asthma | American Journal of Physiology-Lung Cellular and Molecular Physiology | American Physiological Society Most people with severe asthma have obesity. Metabolic dysfunction, often associated with obesity, is particularly associated with severe asthma. Mechanisms linking metabolic dysfunction with asthma, and whether improving metabolic function can affect asthma, are not known. The endocannabinoid system plays a significant role in metabolism; inhibition of cannabinoid receptor 1 (CB1R) induces weight loss and improves serum lipid profiles. We used a CB1R inverse agonist, INV-202, in a mouse model of obese asthma and investigated changes in weight, inflammation, airway reactivity, and surfactant lipids. Mice were fed low or high fat diets (LFD, HFD), and house dust mite extract (HDM) was delivered intranasally to induce allergic airway inflammation. Mice received INV-202 by oral gavage. Airway hyperresponsiveness was measured by flexivent and lung tissue cytokines were measured by ELISA. Leukocytes and lipids in the bronchoalveolar lavage fluid (BALF) were analyzed by flow cytometry and mass spectroscopy, respectively. LFD and HFD mice lost an average of 11% and 27% of their body weight, respectively. LFD mice had a 33% decrease in CCL20 in lung tissue and a 55% decrease in neutrophils in BALF. LFD and HFD mice had improvements in airway hyperresponsiveness, particularly as measured by reduced elastance. Phosphatidylglycerol in BALF increased with INV-202, which significantly correlated with compliance in LFD mice. This study supports a significant contribution of metabolic factors related to the endocannabinoid system in lung compliance and airway reactivity, in part through effects on surfactant lipid composition, and demonstrates the potential of CB1R inverse agonists to treat obese asthma.

Publication alert 🚨Obese #asthma study on cannabinoid receptor offers contributions to future treatments, co-authored with #UVMLarnerMed faculty in Depts. of Medicine, Pathology, Anesthesiology, and Vermont Lung Center: doi.org/10.1152/ajpl...
@uvmvermont.bsky.social @carolynmorris.bsky.social

The first UVM students on campus for orientation are the #UVMLarnerMed Class of 2029! Some #UVMFutureDocs stats: from 22 states, fluent in 16 languages beyond English, arriving from 72 universities and 42 different majors. Learn more:
Go.uvm.edu/classof2029 @uvmvermont.bsky.social

Larner Welcomes 2029 Class of Medical Students | Office of Medical Communications | The University of Vermont The Robert Larner, M.D. College of Medicine at the University of Vermont welcomed its 202nd entering class of 124 new medical students from across the United States on Monday, August 11.

Welcome to our 124 new UVM medical students! It’s day one of a transformative journey. Learn more about our 202nd class. ⬇️ #UVMFutureDocs #UVMLarnerMed

📢As seen on Larner web: “New Risk Calculator Can Better Predict Stroke to Direct the Best Prevention” in Journal of Thrombosis: go.uvm.edu/strokecalc thanks to researchers including Samuel Short, M.D.'23 and
@marycushmanmd.bsky.social of #UVMLarnerMed @unchealth.bsky.social @uvmvermont.bsky.social

Postdoctoral Trainee Deena Snoke, Ph.D., Receives Prestigious NIH Pathway to Independence Award | UVM Cancer Center | The University of Vermont

Deena Snoke, Ph.D., postdoc fellow in the Michael Toth, Ph.D., Lab at #UVMLarnerMed and UVM Cancer Center member was selected for the K99/R00 Pathway to Independence Award from the NCI at NIH. This grant offers up to 5 years of funding. go.uvm.edu/snoke @uvmvermont.bsky.social @snoke-phd.bsky.social

Cancer Center Members Awarded American Cancer Society Research Grants | UVM Cancer Center | The University of Vermont

Danielle Brasino, Ph.D., #UVMLarnerMed assistant prof. in the dept. of MMG and UVM Cancer Center member/researcher Trishnee Bhurosy, Ph.D. received research grants from the @americancancersoc.bsky.social on #foodinsecurity in survivors: go.uvm.edu/foodins @uvmvermont.bsky.social

UVM Researchers Investigate Vermont’s Burgeoning Tick Problem | Office of Medical Communications | The University of Vermont With 202.8 cases per 100,000 people, Vermont leads the nation—second only to Rhode Island—in Lyme disease infections per capita, according to 2022 data. UVM researchers work to understand how that hap...

Recent summary of an article in UVM Magaine featuring #UVMLarnerMed associate professor and Vaccine Testing Center's lead clinical investigator Kristen Pierce, M.D., on her lyme vaccine study. uvm.edu/larnermed/me... #LymeDisease #MedSky #LymeResearch
@uvmvermont.bsky.social